High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$290K
$290,053
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VYGR
S
Voyager Therapeutics, Inc.
Carter Todd Alfred
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-24
$15,694
|
||||||
| VYGR |
Voyager Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-24 | $15,694 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-24 | $17,598 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-24 | $53,807 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-02-24 | $24,347 | S | Form 4 |
|
VYGR
S
Voyager Therapeutics, Inc.
Carter Todd Alfred
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-18
$11,355
|
||||||
| VYGR |
Voyager Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-18 | $11,355 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-18 | $40,006 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-02-18 | $13,354 | S | Form 4 |
|
VYGR
S
Voyager Therapeutics, Inc.
Carter Todd Alfred
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-10
$13,571
|
||||||
| VYGR |
Voyager Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-10 | $13,571 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-10 | $46,086 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-02-10 | $17,591 | S | Form 4 |
| VYGR |
Voyager Therapeutics, Inc.
|
CFO
Sell to Cover
|
2025-10-03 | $36,643 | S | Form 4 |